Abstract:As one of the most aggressive human malignancies, pancreatic cancer is a leading cause of cancer-related deaths worldwide and only about 4 % of patients will live 5 years after diagnosis. Eighty to approximately eighty-five percent of patients are diagnosed with an unresectable or metastatic disease, which is correlated with poor prognosis and low survival rate. Therefore, it is tremendously significant to exploit novel chemicals to prevent and treat pancreatic cancer. Previous research and clinical studies have demonstrated that many natural products derived from traditional Chinese medicine (TCM) such as camptothecin derivatives and vinca alkaloids could be effective antitumor compounds, hinting that TCM is a promising source for developing new antitumor drugs. In this report, we investigated the effects of bufalin, a primary active ingredient of the traditional Chinese medicine Chan-Su, on pancreatic cancer cell lines PANC-1 and CFPAC-1 and studied the underlying molecular mechanism. We found that exposure to bufalin could suppress the proliferation of pancreatic cancer cells time and dose dependently. We used flow cytometry to study the effects of bufalin on apoptosis and cell cycle distribution in PANC-1 and CFPAC-1 cells. The results indicated that bufalin could significantly induce both apoptosis and G2/M cell cycle arrest in pancreatic cancer cells. With western blotting, we found that the expression level of an antiapoptotic protein heat shock protein 27 (Hsp27) and its partner molecule p-Akt was decreased upon the treatment with bufalin. Besides, bufalin activated pro-caspase-3 and pro-caspase-9 and modulated the expression level of Bcl-2 and Bax. These data suggested that bufalin may trigger apoptosis by targeting Hsp27, which could inhibit apoptosis by interfering with key apoptotic proteins. The influence on the level of cylinB1, CDK1, and p21 was also observed after bufalin treatment, and the relationship between Hsp27 and the cell cycle-related proteins mentioned above deserves much more research. In addition, our data showed that bufalin could enhance the growth inhibition effect of gemcitabine in above pancreatic cancer cells. Taken together, bufalin might be worthy of further study for its potential as a therapeutic agent for pancreatic cancer treatment.

Bufalin Induces G2/M Phase Arrest and Triggers Autophagy Via the Tnf, Jnk, Becn-1 and Atg8 Pathway in Human Hepatoma Cells

Bufalin Increases Sensitivity to Akt/Mtor-Induced Autophagic Cell Death in Sk-Hep-1 Human Hepatocellular Carcinoma Cells

Blocking Autophagy Enhances the Apoptosis Effect of Bufalin on Human Hepatocellular Carcinoma Cells Through Endoplasmic Reticulum Stress and Jnk Activation

Bufalin Inhibits Htert Expression and Colorectal Cancer Cell Growth by Targeting CPSF4

Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice

The biological role of autophagy in regulating and controlling the proliferation of liver cancer cells induced by bufalin.

Inhibitory effect of bufalin combined with Hedgehog signaling pathway inhibitors on proliferation and invasion and metastasis of liver cancer cells.

Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patients.

Global Metabolomic and Lipidomic Analysis Reveal the Synergistic Effect of Bufalin in Combination with Cinobufagin Against HepG2 Cells.

Bufalin Inhibits Migration and Invasion in Human Hepatocellular Carcinoma SK-Hep1 Cells Through the Inhibitions of NF-kB and Matrix Metalloproteinase-2/-9-signaling Pathways.

Ursolic Acid Induces Cell Cycle Arrest and Apoptosis of Gallbladder Carcinoma Cells

Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma

Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells

Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells

Blocking autophagy enhances the pro-apoptotic effect of bufalin on human gastric cancer cells through endoplasmic reticulum stress

Bufalin Inhibits Tumorigenesis and SREBP-1-Mediated Lipogenesis in Hepatocellular Carcinoma Via Modulating the ATP1A1/CA2 Axis

Na+/K+-Atpase Alpha 3 Mediates Sensitivity Of Hepatocellular Carcinoma Cells To Bufalin

Bufalin attenuates the proliferation of breast cancer MCF-7 cells in vitro and in vivo by inhibiting the PI 3 K / Akt pathway

Bufalin Enhances the Anti-Proliferative Effect of Sorafenib on Human Hepatocellular Carcinoma Cells Through Downregulation of ERK

The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma

Bufalin Suppresses Hepatocellular Carcinoma Invasion and Metastasis by Targeting HIF-1α Via the PI3K/AKT/mTOR Pathway.